Cited by 279HIV-related health complications and treatmentsHIV Research and TreatmentHIV/AIDS Research and Interventions

The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.

. Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.

Open access

Tien, Phyllis C, Choi, Andy I, Zolopa, Andrew R, Benson, Constance, Tracy, Russell, Scherzer, Rebecca, Bacchetti, Peter, Shlipak, Michael, Grunfeld, Carl·2010·JAIDS Journal of Acquired Immune Deficiency Syndromes

DOI 10.1097/qai.0b013e3181e66216PMC PMC2955817

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To determine the association of inflammatory markers, fibrinogen, and C-reactive protein (CRP), with 5-year mortality risk. METHODS: Vital status was ascertained in 922 HIV-infected participants from the Study of Fat Redistribution and Metabolic Change in HIV infection. Multivariable logistic regression estimated odds ratios after adjustment for demographic, cardiovascular, and HIV-related factors. RESULTS: Over a 5-year period, HIV-infected participants with fibrinogen levels in the highest tertile (>406 mg/dL) had 2.6-fold higher adjusted odds of death than those with fibrinogen in the lowest tertile (<319 mg/dL). Those with high CRP (>3 mg/L) had 2.7-fold higher adjusted odds of death than those with CRP <1 mg/L. When stratified by CD4 count category, fibrinogen (as a linear variable) remained independently associated [odds ratio (95% confidence intervals)] per 100 mg/dL increase in fibrinogen: 1.93 (1.57 to 2.37); 1.43 (1.14 to 1.79); 1.43 (1.14 to 1.81); and 1.30 (1.04 to 1.63) for CD4 <200, 200-350, >350 to 500, and >500 cells per microliter, respectively. Higher CRP also remained associated with higher odds of death overall and within each CD4 subgroup. CONCLUSIONS: Fibrinogen and CRP are strong and independent predictors of mortality in HIV-infected adults. Our findings suggest that even in those with relatively preserved CD4 counts >500 cells per microliter, inflammation remains an important risk factor for mortality. Further investigation should determine whether interventions to reduce inflammation might decrease mortality risk in HIV-infected individuals.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1097/qai.0b013e3181e66216

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,393
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification
Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., & Eknoyan, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00013 · Cited by 4,615
Multiple imputation: a primer
Schafer, J. L. (1999) · Statistical Methods in Medical Research · doi:10.1177/096228029900800102 · Cited by 3,949
Marginal Structural Models to Estimate the Causal Effect of Zidovudine on the Survival of HIV-Positive Men
Hernán, M. Á., Brumback, B., & Robins, J. M. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00012 · Cited by 1,772
. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617
Mortality in the Highly Active Antiretroviral Therapy Era
Palella, F. J., Baker, R. K., Moorman, A. C., Chmiel, J. S., Wood, K. C., Brooks, J. T., & Holmberg, S. D. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000233310.90484.16 · Cited by 1,362
Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality
Danesh, J., Lewington, S., Thompson, S. G., Lowe, G. D. O., Collins, R., Kostis, J. B., Wilson, A. C., Folsom, A. R., Wu, K., Benderly, M., et al. (2005) · JAMA · doi:10.1001/jama.294.14.1799 · Cited by 1,162
Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus
The Data Collection on Adverse Events of Anti-HIV Drugs Study Group* (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1632 · Cited by 1,115
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
Kitahata, M. M., Gange, S. J., Abraham, A. G., Merriman, B., Saag, M. S., Justice, A. C., Hogg, R. S., Deeks, S. G., Eron, J. J., Brooks, J. T., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807252 · Cited by 1,105
Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study
Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,098

Show all 28 references

Sorted by citations

Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
Murray, D. D., Suzuki, K., Law, M. G., Trebicka, J., Neuhaus, J., Wentworth, D. N., Johnson, M. A., Vjecha, M. J., Kelleher, A. D., Emery, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139981 · Cited by 2,740
Systemic Effects of Inflammation on Health during Chronic HIV Infection
Deeks, S. G., Tracy, R. P., & Douek, D. C. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.001 · Cited by 910
Soluble Markers of Inflammation and Coagulation but Not T-Cell Activation Predict Non–AIDS-Defining Morbid Events During Suppressive Antiretroviral Treatment
Tenorio, A. R., Zheng, Y., Bosch, R. J., Krishnan, S., Rodriguez, B. A., Hunt, P. W., Plants, J., Seth, A., Wilson, C. C., Deeks, S. G., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu254 · Cited by 551
HIV and Aging: State of Knowledge and Areas of Critical Need for Research. A Report to the NIH Office of AIDS Research by the HIV and Aging Working Group
High, K. P., Brennan-Ing, M., Clifford, D. B., Cohen, M. H., Currier, J., Deeks, S. G., Deren, S., Effros, R. B., Gebo, K., Goronzy, J. J., et al. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31825a3668 · Cited by 522
Self-citation
Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection
Hunt, P. W., Sinclair, E., Rodriguez, B. A., Shive, C. L., Clagett, B. M., Funderburg, N., Robinson, J., Huang, Y., Epling, L., Martin, J. N., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu238 · Cited by 481
HIV and Inflammation: Mechanisms and Consequences
Hunt, P. W. (2012) · Current HIV/AIDS Reports · doi:10.1007/s11904-012-0118-8 · Cited by 431
Residual Immune Dysregulation Syndrome in Treated HIV infection
Lederman, M. M., Funderburg, N., Sékaly, R., Klatt, N. R., & Hunt, P. W. (2013) · Advances in immunology · doi:10.1016/b978-0-12-407707-2.00002-3 · Cited by 348
Patterns of Cardiovascular Mortality for HIV-Infected Adults in the United States: 1999 to 2013
Feinstein, M. J., Bahiru, E. M., Achenbach, C. J., Longenecker, C. T., Hsue, P. Y., So‐Armah, K., Freiberg, M. S., & Lloyd‐Jones, D. M. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.10.030 · Cited by 300
Current understanding of HIV-associated neurocognitive disorders pathogenesis
Gannon, P. J., Khan, M. Z., & Kolson, D. L. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32834695fb · Cited by 274
Immunologic Basis of Cardiovascular Disease in HIV-Infected Adults
Hsue, P. Y., Deeks, S. G., & Hunt, P. W. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis200 · Cited by 281
Sudden Cardiac Death in Patients With Human Immunodeficiency Virus Infection
Tseng, Z. H., Secemsky, E. A., Dowdy, D. W., Vittinghoff, E., Moyers, B., Wong, J. K., Havlir, D. V., & Hsue, P. Y. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.024 · Cited by 269
Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection
Hunt, P. W., Lee, S. A., & Siedner, M. J. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw275 · Cited by 276
HIV and Coronary Heart Disease
Boccara, F., Lang, S., Meuleman, C., Éderhy, S., Mary‐Krause, M., Costagliola, D. G., Capeau, J., & Cohen, A. A. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.063 · Cited by 261
Causes of death among HIV-infected patients in France in 2010 (national survey)
Morlat, P., Roussillon, C., Hénard, S., Salmon, D., Bonnet, F., Cacoub, P., Georget, A., Aouba, A., Rosenthal, É., May, T., et al. (2014) · AIDS · doi:10.1097/qad.0000000000000222 · Cited by 257
HIV Treatment Outcomes Among HIV-Infected, Opioid-Dependent Patients Receiving Buprenorphine/Naloxone Treatment within HIV Clinical Care Settings: Results From a Multisite Study
Altice, F. L., Bruce, R. D., Lucas, G. M., Lum, P. J., Korthuis, P. T., Flanigan, T., Cunningham, C. O., Sullivan, L. E., Vergara‐Rodriguez, P., Fiellin, D. A., et al. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318209751e · Cited by 257
Cardiovascular Disease and HIV Infection
Triant, V. A. (2013) · Current HIV/AIDS Reports · doi:10.1007/s11904-013-0168-6 · Cited by 236
HIV infection and coronary heart disease: mechanisms and management
Hsue, P. Y., & Waters, D. D. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0219-9 · Cited by 237
Gut epithelial barrier and systemic inflammation during chronic HIV infection
Somsouk, M., Estes, J. D., Deléage, C., Dunham, R. M., Albright, R. G., Inadomi, J. M., Martin, J. N., Deeks, S. G., McCune, J. M., & Hunt, P. W. (2014) · AIDS · doi:10.1097/qad.0000000000000511 · Cited by 203
Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy
Grund, B., Baker, J. V., Deeks, S. G., Wolfson, J. A., Wentworth, D. N., Cozzi‐Lepri, A., Cohen, C. J., Phillips, A. N., Lundgren, J. D., Neaton, J. D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155100 · Cited by 208
Platelets in Immune Response to Virus and Immunopathology of Viral Infections
Hottz, E. D., Bozza, F. A., & Bozza, P. T. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00121 · Cited by 185
Efficacy of the CCR5 Antagonist Maraviroc in Reducing Early, Ritonavir-Induced Atherogenesis and Advanced Plaque Progression in Mice
Cipriani, S., Francisci, D., Mencarelli, A., Renga, B., Schiaroli, E., D’Amore, C., Baldelli, F., & Fiorucci, S. (2013) · Circulation · doi:10.1161/circulationaha.113.001278 · Cited by 154
Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence.
Dock, J., & Effros, R. B. (2011) · Europe PMC (PubMed Central) · Cited by 137
The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial
Hunt, P. W., Shulman, N. S., Hayes, T. L., Dahl, V., Somsouk, M., Funderburg, N., McLaughlin, B. E., LANDAY, A. L., Adeyemi, O. M., Gilman, L. T., et al. (2013) · Blood · doi:10.1182/blood-2012-06-436345 · Cited by 138
Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection
Scherzer, R., Heymsfield, S. B., Lee, D., Powderly, W. G., Tien, P. C., Bacchetti, P., Shlipak, M. G., & Grünfeld, C. (2011) · AIDS · doi:10.1097/qad.0b013e32834884e6 · Cited by 134
Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients
The Antiretroviral Therapy Cohort Collaboration (ART-CC) (2015) · AIDS · doi:10.1097/qad.0000000000000544 · Cited by 120
Disparities in Prevalence of Key Chronic Diseases by Gender and Race/Ethnicity among Antiretroviral-Treated HIV-Infected Adults in the Us
Buchacz, K. A., Baker, R. K., Palella, F. J., Shaw, L., Patel, P., Lichtenstein, K. A., Chmiel, J. S., Vellozzi, C. J., Debes, R., Henry, K., et al. (2012) · Antiviral Therapy · doi:10.3851/imp2450 · Cited by 126
Premature Aging and Premature Age-Related Comorbidities in HIV-Infected Patients: Facts and Hypotheses
Capeau, J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir628 · Cited by 125
Cystatin C, Albuminuria, and 5-Year All-Cause Mortality in HIV-Infected Persons
Choi, A. I., Scherzer, R., Bacchetti, P., Tien, P. C., Saag, M. S., Gibert, C. L., Szczech, L. A. M., Grünfeld, C., & Shlipak, M. G. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.05.019 · Cited by 110
HIV-1–Related Cardiovascular Disease Is Associated With Chronic Inflammation, Frequent Pericardial Effusions, and Probable Myocardial Edema
Ntusi, N., O’Dwyer, E., Dorrell, L., Wainwright, E., Piechnik, S. K., Clutton, G., Hancock, G., Ferreira, V. M., Cox, P., Badri, M., et al. (2016) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.115.004430 · Cited by 110
Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients
Funderburg, N. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000019 · Cited by 105
Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection
Hsu, D. C., & Sereti, I. (2016) · Drugs · doi:10.1007/s40265-016-0546-7 · Cited by 102
HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammation
Gootenberg, D. B., Paer, J. M., Luévano, J. M., & Kwon, D. S. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000341 · Cited by 103
Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation
Zidar, D. A., Juchnowski, S. M., Ferrari, B., Clagett, B. M., Pilch-Cooper, H. A., Rose, S. M., Rodriguez, B. A., McComsey, G. A., Sieg, S. F., Mehta, N. N., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000566 · Cited by 102
Replication of CMV in the gut of HIV-infected individuals and epithelial barrier dysfunction
Maidji, E., Somsouk, M., Rivera, J. M., Hunt, P. W., & Stoddart, C. A. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006202 · Cited by 102
Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression
Castillo‐Mancilla, J., Brown, T. T., Erlandson, K. M., Palella, F. J., Gardner, E. M., Macatangay, B. J. C., Breen, E. C., Jacobson, L. P., Anderson, P. L., & Wada, N. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw650 · Cited by 101
Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapy
Hsu, D. C., Ma, Y. F., Hur, S., Li, D., Rupert, A. W., Scherzer, R., Kalapus, S. C., Deeks, S. G., Sereti, I., & Hsue, P. Y. (2016) · AIDS · doi:10.1097/qad.0000000000001149 · Cited by 101
High rates of hypertension, diabetes, elevated low-density lipoprotein cholesterol, and cardiovascular disease risk factors in HIV-infected patients in Malawi
Rücker, S. C. M., Tayea, A., Bitilinyu-Bangoh, J., Aza, E. B., Salumu, L., Quiles, I. A., Szumilin, E., Chirwa, Z., Rick, F., & Maman, D. (2017) · AIDS · doi:10.1097/qad.0000000000001700 · Cited by 96
Cardiovascular Disease and Thrombosis in HIV Infection
Perkins, M. V., Joseph, S., Dittmer, D. P., & Mackman, N. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318232 · Cited by 98
Circulating Interleukin-6 Levels Correlate with Residual HIV Viraemia and Markers of Immune Dysfunction in Treatment-Controlled HIV-Infected Patients
Bastard, J., Soulié, C., Fellahi, S., Haïm‐Boukobza, S., Simon, A., Katlama, C., Cálvez, V., Marcelin, A., & Capeau, J. (2012) · Antiviral Therapy · doi:10.3851/imp2093 · Cited by 90
Performance of Creatinine and Cystatin C GFR Estimating Equations in an HIV-Positive Population on Antiretrovirals
Inker, L. A., Wyatt, C. M., Creamer, R., Hellinger, J., Hotta, M., Leppo, M., Levey, A. S., Okparavero, A., Graham, H., Savage, K., et al. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31826a6c4f · Cited by 89
Inflammatory Biomarkers and Mortality Risk Among HIV-Suppressed Men: A Multisite Prospective Cohort Study
Wada, N., Bream, J. H., Martı́nez-Maza, O., Macatangay, B. J. C., Galvin, S., Margolick, J. B., & Jacobson, L. P. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw409 · Cited by 87
Inflammatory Cytokines Drive CD4+ T-Cell Cycling and Impaired Responsiveness to Interleukin 7: Implications for Immune Failure in HIV Disease
Shive, C. L., Mudd, J. C., Funderburg, N., Sieg, S. F., Kyi, B., Bazdar, D. A., Mangioni, D., Gori, A., Jacobson, J. M., Brooks, A. D., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu125 · Cited by 82
Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial
Baker, J. V., Sharma, S., Grund, B., Rupert, A. W., Metcalf, J. A., Schechter, M., Munderi, P., Aho, I., Emery, S., Babiker, A. G., et al. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx262 · Cited by 83
Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV
Musselwhite, L. W., Sheikh, V., Norton, T. D., Rupert, A. W., Porter, B. O., Penzak, S. R., Skinner, J., Mican, J. M., Hadigan, C. M., & Sereti, I. (2011) · AIDS · doi:10.1097/qad.0b013e3283453fcb · Cited by 83
Dimethyl Fumarate Modulation of Immune and Antioxidant Responses: Application to HIV Therapy
Gill, A. J., & Kolson, D. L. (2013) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2013007247 · Cited by 81
The Many Faces of Immune Activation in HIV-1 Infection: A Multifactorial Interconnection
Mazzuti, L., Turriziani, O., & Mezzaroma, I. (2023) · Biomedicines · doi:10.3390/biomedicines11010159 · Cited by 77
Accelerated aging and human immunodeficiency virus infection: Emerging challenges of growing older in the era of successful antiretroviral therapy
Bhatia, R., Ryscavage, P., & Taiwo, B. (2011) · Journal of NeuroVirology · doi:10.1007/s13365-011-0073-y · Cited by 80
Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART
Stiksrud, B., Nowak, P., Nwosu, F. C., Kvale, D., Thalme, A., Sönnerborg, A. B., Ueland, P. M., Holm, K., Birkeland, S., Dahm, A. E. A., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000784 · Cited by 77
Soluble biomarkers of HIV transmission, disease progression and comorbidities
Leeansyah, E., Malone, D. F. G., Anthony, D. D., & Sandberg, J. K. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835c7134 · Cited by 76
Cardiovascular implications from untreated human immunodeficiency virus infection
Baker, J. V., & Lundgren, J. D. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq483 · Cited by 75
Serious Non-AIDS events: Immunopathogenesis and interventional strategies
Hsu, D. C., Sereti, I., & Ananworanich, J. (2013) · AIDS Research and Therapy · doi:10.1186/1742-6405-10-29 · Cited by 73
Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults
Mave, V., Erlandson, K. M., Gupte, N., Balagopal, A., Asmuth, D. M., Campbell, T., Smeaton, L. M., Kumarasamy, N., Hakim, J., Santos, B. R., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw096 · Cited by 76
Persistent platelet activation and apoptosis in virologically suppressed HIV-infected individuals
Mesquita, E. C., Hottz, E. D., Amancio, R. T., Carneiro, A. B., Palhinha, L., Coelho, L. E., Grinsztejn, B. G. J., Zimmerman, G. A., Rondina, M. T., Weyrich, A. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33403-0 · Cited by 73
Inflammation-Related Morbidity and Mortality Among HIV-Positive Adults: How Extensive Is It?
Hart, B. B., Nordell, A. D., Okulicz, J. F., Palfreeman, A., Horban, A., Kedem, E., Neuhaus, J., Jacobs, D. R., Duprez, D. A., Neaton, J. D., et al. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001554 · Cited by 77
Association of Low Level Viremia with Inflammation and Mortality in HIV-Infected Adults
Eastburn, A., Scherzer, R., Zolopa, A. R., Benson, C. A., Tracy, R. P., Do, T., Bacchetti, P., Shlipak, M. G., Grünfeld, C., & Tien, P. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026320 · Cited by 72
HIV Replication Alters the Composition of Extrinsic Pathway Coagulation Factors and Increases Thrombin Generation
Baker, J. V., Brummel‐Ziedins, K. E., Neuhaus, J., Duprez, D. A., Cummins, N. W., Dalmau, D., DeHovitz, J. A., Lehmann, C., Sullivan, A. K., Woolley, I. J., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000264 · Cited by 71
Biomarkers and HIV-associated cardiovascular disease
Baker, J. V., & Duprez, D. A. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833ed7ec · Cited by 76
Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment
Elvstam, O., Medstrand, P., Yilmaz, A., Isberg, P., Gisslén, M., & Björkman, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180761 · Cited by 70
Excess Soluble CD40L Contributes to Blood Brain Barrier Permeability In Vivo: Implications for HIV-Associated Neurocognitive Disorders
Davidson, D. C., Hirschman, M. P., Sun, A., Singh, M. V., Kasischke, K. A., & Maggirwar, S. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051793 · Cited by 71
Decreased Lung Function and All-Cause Mortality in HIV-infected Individuals
Gingo, M. R., Nouraie, M. S., Kessinger, C. J., Greenblatt, R. M., Huang, L., Kleerup, E. C., Kingsley, L., McMahon, D. K., & Morris, A. M. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201606-492oc · Cited by 69
Managing HIV‐associated inflammation and ageing in the era of modern ART
Bloch, M. T., John, M., Smith, D. E., Rasmussen, T. A., & Wright, E. (2020) · HIV Medicine · doi:10.1111/hiv.12952 · Cited by 74
The Immunologic Effects of Mesalamine in Treated HIV-Infected Individuals with Incomplete CD4+ T Cell Recovery: A Randomized Crossover Trial
Somsouk, M., Dunham, R. M., Cohen, M. L., Albright, R. G., Abdel‐Mohsen, M., Liegler, T. J., Lifson, J. D., Piatak, M., Gorelick, R. J., Huang, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116306 · Cited by 67
HIV, dementia and antiretroviral drugs: 30 years of an epidemic
Manji, H., Jäger, H. R., & Winston, A. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304022 · Cited by 69
Aging, Health, and Quality of Life for Older People Living With HIV in Sub-Saharan Africa: A Review and Proposed Conceptual Framework
Siedner, M. J. (2017) · Journal of Aging and Health · doi:10.1177/0898264317724549 · Cited by 68
Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus
Marconi, V. C., Moser, C., Gavegnano, C., Deeks, S. G., Lederman, M. M., Overton, E. T., Tsibris, A. M. N., Hunt, P. W., Kantor, A., Sékaly, R., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab212 · Cited by 65
Persistent low-Level viremia in persons living with HIV undertreatment: An unresolved status
Crespo‐Bermejo, C., de Arellano, E. R., Lara‐Aguilar, V., Valle‐Millares, D., Gómez-Lus, M. L., Madrid, R., Martín‐Carbonero, L., & Briz, V. (2021) · Virulence · doi:10.1080/21505594.2021.2004743 · Cited by 69
Role of T‐Cell Dysfunction, Inflammation, and Coagulation in Microvascular Disease in HIV
Sinha, A., Ma, Y., Scherzer, R., Hur, S., Li, D., Ganz, P., Deeks, S. G., & Hsue, P. Y. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004243 · Cited by 68
Opioids Impair Intestinal Epithelial Repair in HIV-Infected Humanized Mice
Meng, J., Banerjee, S., Zhang, L., Sindberg, G. M., Moidunny, S., Li, B., Robbins, D. J., Girotra, M., Segura, B. J., Ramakrishnan, S., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02999 · Cited by 65
Race/ethnicity moderates the relationship between depressive symptom severity and C-reactive protein: 2005–2010 NHANES data
Case, S. M., & Stewart, J. C. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.04.004 · Cited by 63
Age, stress, and isolation in older adults living with HIV
Webel, A. R., Longenecker, C. T., Gripshover, B., Hanson, J. E., Schmotzer, B. J., & Salata, R. A. (2013) · AIDS Care · doi:10.1080/09540121.2013.845288 · Cited by 65
Potential Cardiovascular Disease Risk Markers Among HIV-Infected Women Initiating Antiretroviral Treatment
Kaplan, R. C., LANDAY, A. L., Hodis, H. N., Gange, S. J., Norris, P. J., Young, M., Anastos, K., Tien, P. C., Xue, X., Lazar, J., et al. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31825b03be · Cited by 60
Chronic Inflammation and the Role for Cofactors (Hepatitis C, Drug Abuse, Antiretroviral Drug Toxicity, Aging) in HAND Persistence
Gill, A. J., & Kolson, D. L. (2014) · Current HIV/AIDS Reports · doi:10.1007/s11904-014-0210-3 · Cited by 61
Innate Immune Responses and Rapid Control of Inflammation in African Green Monkeys Treated or Not with Interferon-Alpha during Primary SIVagm Infection
Jacquelin, B., Petitjean, G., Kunkel, D., Liovat, A.-S., Jochems, S. P., Rogers, K. A., Ploquin, M. J.-Y., Madec, Y., Barré‐Sinoussi, F., Dereuddre‐Bosquet, N., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004241 · Cited by 58
Elevated rates of intracerebral hemorrhage in individuals from a US clinical care HIV cohort
Chow, F. C., He, W. W., Bacchetti, P., Regan, S., Feske, S. K., Meigs, J. B., Grinspoon, S. K., & Triant, V. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000958 · Cited by 57
Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes
Liu, N., Jiang, C., Cai, P., Shen, Z., Sun, W., Xu, H. Y., Fang, M., Yao, X., Zhu, L., Gao, X., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109793 · Cited by 55
Baseline Kidney Function as Predictor of Mortality and Kidney Disease Progression in HIV-Positive Patients
Ibrahim, F., Hamzah, L., Jones, R., Nitsch, D., Sabin, C. A., & Post, F. A. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.03.006 · Cited by 56
Inflammatory biomarkers and subclinical carotid atherosclerosis in HIV-infected and HIV-uninfected men in the Multicenter AIDS Cohort Study
Subramanya, V., McKay, H., Brusca, R. M., Palella, F. J., Kingsley, L., Witt, M. D., Hodis, H. N., Tracy, R. P., Post, W. S., & Haberlen, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214735 · Cited by 56
Coagulation and morbidity in treated HIV infection
Funderburg, N., & Lederman, M. M. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.03.012 · Cited by 54
Oxidative Stress Predicts All-Cause Mortality in HIV-Infected Patients
Masiá, M., Padilla, S., Fernández‐González, M., Rodríguez, C., Moreno, A. M., Oteo, J. A., Antela, A., Moreno, S., del Amo, J., Gutiérrez, F., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153456 · Cited by 54
Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy
Llibre, J. M., Arribas, J. R., Domingo, P., Gatell, J. M., Lozano, F., Santos, J. R., Rivero, A., Moreno, S., & Clotet, B. (2011) · AIDS · doi:10.1097/qad.0b013e3283499cd9 · Cited by 53
Chronic HIV disease and activation of the coagulation system
Baker, J. V. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.08.016 · Cited by 52
Statin Therapy Decreases Serum Levels of High-Sensitivity C-Reactive Protein and Tumor Necrosis Factor-α in HIV-Infected Patients Treated With Ritonavir-Boosted Protease Inhibitors
Calza, L., Trapani, F., Bartoletti, M., Manfredi, R., Colangeli, V., Borderi, M., Grossi, G., Motta, R., & Viale, P. (2012) · HIV Clinical Trials · doi:10.1310/hct1303-153 · Cited by 51
Increased inflammation but similar physical composition and function in older-aged, HIV-1 infected subjects
Wallet, M. A., Buford, T. W., Joseph, A.-M., Sankuratri, M., Leeuwenburgh, C., Pahor, M., Manini, T. M., Sleasman, J. W., & Goodenow, M. M. (2015) · BMC Immunology · doi:10.1186/s12865-015-0106-z · Cited by 52
Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection
Carrico, A. W., Cherenack, E. M., Roach, M. E., Riley, E. D., Oni, O., Dilworth, S. E., SHOPTAW, S. J., Hunt, P. W., Roy, S., Pallikkuth, S., et al. (2018) · AIDS · doi:10.1097/qad.0000000000001751 · Cited by 49
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns
Falasca, F., Carlo, D. D., Vito, C. D., Bon, I., d’Ettorre, G., Fantauzzi, A., Mezzaroma, I., Fimiani, C., Re, M. C., Vullo, V., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2676-2 · Cited by 48
The Effect of HIV and HPV Coinfection on Cervical COX-2 Expression and Systemic Prostaglandin E2 Levels
Fitzgerald, D. W., Bezak, K. B., Ocheretina, O., Riviere, C., Wright, T. C., Milne, G. L., Zhou, X. K., Du, B., Subbaramaiah, K., Byrt, E., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0496 · Cited by 46
HIV and aging
Hunt, P. W. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000072 · Cited by 47
Viremic and Virologically Suppressed HIV Infection Increases Age-Related Changes to Monocyte Activation Equivalent to 12 and 4 Years of Aging, Respectively
Angelovich, T. A., Hearps, A. C., Maisa, A., Martin, G. E., Lichtfuss, G. F., Cheng, W., Palmer, C. S., LANDAY, A. L., Crowe, S. M., & Jaworowski, A. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000559 · Cited by 44
Cardiovascular Complications of HIV in Endemic Countries
Feinstein, M. J., Bogorodskaya, M., Bloomfield, G. S., Vedanthan, R., Siedner, M. J., Kwan, G. F., & Longenecker, C. T. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0794-x · Cited by 48
Systemic inflammation-based scores and mortality for all causes in HIV-infected patients: a MASTER cohort study
Raffetti, E., Donato, F., Casari, S., Castelnuovo, F., Sighinolfi, L., Bandera, A., Maggiolo, F., Ladisa, N., Pietro, M. D., Fornabaio, C., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2280-5 · Cited by 44
High-sensitivity C-reactive protein levels fall during statin therapy in HIV-infected patients receiving ritonavir-boosted protease inhibitors
Aslangul, E., Fellahi, S., Assoumou, L., Bastard, J., Capeau, J., & Costagliola, D. G. (2011) · AIDS · doi:10.1097/qad.0b013e328346be29 · Cited by 42
Persistently Elevated Serum Interleukin-6 Predicts Mortality Among Adults Receiving Combination Antiretroviral Therapy in Botswana: Results from a Clinical Trial
McDonald, B., Moyo, S. M., Gabaitiri, L., Gaseitsiwe, S., Bussmann, H., Koethe, J. R., Musonda, R. M., Makhema, J. M., Novitsky, V., Marlink, R., et al. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2012.0309 · Cited by 41
Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities
Ghislain, M., Bastard, J., Meyer, L., Capeau, J., Fellahi, S., Gérard, L., May, T., Simon, A., Vigouroux, C., Goujard, C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144317 · Cited by 41
START or SMART? Timing of Antiretroviral Therapy Initiation and Cardiovascular Risk for People With Human Immunodeficiency Virus Infection
Siedner, M. J. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw032 · Cited by 41
Does systemic inflammation and immune activation contribute to fracture risk in HIV?
McGinty, T., Mirmonsef, P., Mallon, P. W. G., & LANDAY, A. L. (2016) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000275 · Cited by 41
FRAILTY AND PRE-FRAILTY IN A CONTEMPORARY COHORT OF HIV-INFECTED ADULTS
Önen, N., Patel, P., Baker, J. V., Conley, L. J., Brooks, J. T., Bush, T. J., Henry, K., Hammer, J., Kojic, E. M., & Overton, E. T. (2014) · The Journal of Frailty & Aging · doi:10.14283/jfa.2014.18 · Cited by 41
Understanding mechanisms to promote successful aging in persons living with HIV
Escota, G. V., O’Halloran, J. A., Powderly, W. G., & Presti, R. M. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.11.010 · Cited by 38
Multivariate Computational Analysis of Gamma Delta T Cell Inhibitory Receptor Signatures Reveals the Divergence of Healthy and ART-Suppressed HIV+ Aging
Belkina, A. C., Starchenko, A., Drake, K., Proctor, E. A., Pihl, R. M. F., Olson, A., Lauffenburger, D. A., Lin, N., & Snyder-Cappione, J. E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02783 · Cited by 39
Brief Report: Integrase Strand Transfer Inhibitors Are Associated With Lower Risk of Incident Cardiovascular Disease in People Living With HIV
O’Halloran, J. A., Sahrmann, J. M., Butler, A. M., Olsen, M. A. A., & Powderly, W. G. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002357 · Cited by 39
P2X Antagonists Inhibit HIV-1 Productive Infection and Inflammatory Cytokines Interleukin-10 (IL-10) and IL-1β in a Human Tonsil Explant Model
Soare, A. Y., Durham, N. D., Gopal, R., Tweel, B. C., Hoffman, K. W., Brown, J. A., O’Brien, M., Bhardwaj, N., Lim, J. K., Chen, B. K., et al. (2018) · Journal of Virology · doi:10.1128/jvi.01186-18 · Cited by 36

Authors: Tien, P. C., Choi, A. I., Zolopa, A. R., Benson, C., Tracy, R., Scherzer, R., Bacchetti, P., Shlipak, M., & Grunfeld, C.
Affiliations: San Francisco VA Medical Center (US)
Stanford Medicine (US)
University of California San Diego (US)
University of California, San Francisco (US)
Corresponding author: Tien, Phyllis C
Choi, Andy I
Scherzer, Rebecca
Shlipak, Michael
ORCID: Tien, Phyllis C
Benson, Constance
Tracy, Russell
Scherzer, Rebecca
Bacchetti, Peter
Shlipak, Michael
Venue: JAIDS Journal of Acquired Immune Deficiency Syndromes
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2010-11-01
Volume: 55
Issue: 3
Pages: 316-322
ISSN: 1525-4135 (ISSN-L)
DOI: 10.1097/qai.0b013e3181e66216
PMC: PMC2955817
OpenAlex: W2046166857
Cited by: 279
References: 28
Citations by year: 2026: 3 · 2025: 6 · 2024: 3 · 2023: 10 · 2022: 16 · 2021: 17 · 2020: 15 · 2019: 13 · 2018: 18 · 2017: 21 · 2016: 26 · 2015: 23 · 2014: 24 · 2013: 31 · 2012: 25
FWCI: 25.25
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: JAIDS Journal of Acquired Immune Deficiency Syndromes (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (2m01rr000083-41)
National Heart, Lung, and Blood Institute (HL-53359, R01HL053359, HL-74814, R01HL074814)
National Institute of Allergy and Infectious Diseases (K23AI066943)
National Institute of Diabetes and Digestive and Kidney Diseases (DK080645, R01DK057508, K23DK080645)
National Center for Research Resources (RR00054, UL1RR024131, RR-00051, RR 0636, M01RR000054, M01RR000051, RR 000 52, M01RR000052, M01-RR000083, RR00865, M01RR000865, RR 00083, M01RR000036)
Topics: Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords: HIV infection, inflammation, mortality, fibrinogen, C-reactive protein, inflammatory markers, CD4 count, mortality risk factors
MeSH terms: Adult, C-Reactive Protein, Female, Fibrinogen, Humans, Inflammation, Male, Middle Aged, Prognosis, HIV Infections, Survival Analysis, CD4 Lymphocyte Count

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

. Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks